Dulbecco''s Phosphate-Buffered Saline

Phase 1

OOhio State University Comprehensive Cancer Center

Dulbecco''s Phosphate-Buffered Saline is one of 6 therapeutic programs targeting Kidney. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

KidneyRecruiting

KidneyPhase 1

Recruiting

Competition

Competitive Landscape

10 competitors in Kidney

#DrugCompanyPhaseTrials

TCD601

IITB-Med LLC

Phase 2

1 2

Sglt2i

UUniversity of Chicago

Phase 2

1 3

Peptide Vaccine

UUniversity Hospital Tuebingen

Phase 1

1 4

QS21

MMemorial Sloan Kettering Cancer Center

Phase 1

1 5

Glypressin

MMallinckrodt

Preclinical

1 6

Dulbecco''s Phosphate-Buffered Saline

OOhio State University Comprehensive Cancer Center

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 1Recruiting

Kidney

NCT06741072

Clinical

Trials by Indication[1]

Kidney1 trial

A Phase 1B Double Blinded Randomized Trial Evaluating Safety, Tolerability, and Immune Response of OSU-2131 a BZLF1 Peptide Vaccine With Stimulon™ QS-21 Solution Adjuvant in Healthy Volunteers and Patients Awaiting Solid Organ Transplantation

Recruiting·OOhio State University Comprehensive Cancer Center·Phase 1·NCT06741072·55 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Dulbecco''s Phosphate-Buffered Saline. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Dulbecco''s Phosphate-Buffered Saline. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Ohio State University Comprehensive Cancer Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 1[1]
Company: OOhio State University Comprehensive Cancer Center

Dulbecco''s Phosphate-Buffered Saline

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Kidney1 trial

References

Drug Info

Quick Facts

Related News